Viridian Therapeutics Shares Are Trading Higher After the Company Announced It Will Release Its VRDON-001 Phase 3 THRIVE Topline Results on Conference Call and Webcast Tuesday Morning.
Viridian Therapeutics Shares Are Trading Higher After the Company Announced It Will Release Its VRDON-001 Phase 3 THRIVE Topline Results on Conference Call and Webcast Tuesday Morning.
Viridian Therapeutics公司宣佈將在週二上午通過電話會議和網絡直播發布其VRDON-001第三階段THRIVE試驗的最新結果時，其股價上漲。
Viridian Therapeutics Shares Are Trading Higher After the Company Announced It Will Release Its VRDON-001 Phase 3 THRIVE Topline Results on Conference Call and Webcast Tuesday Morning.
Viridian Therapeutics宣佈將在週二上午的電話會議和網絡直播中公佈其 VRDON-001 第三階段 THRIVE Topline 業績，此後，該公司股價走高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。